Fig. 5
From: High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth
Association analysis of drug proteomics and clinical data of liver cancer patients. a Comparative analysis of the drug proteome and clinical liver cancer patient’s proteome and The Cancer Genome Atlas (TCGA) liver cancer patient’s transcriptome data. b The relationship between drug-regulated cholesterol dysregulation proteins and the survival of liver cancer patients